Pfizer seeks emergency license for COVID-19 vaccine

Pfizer has announced that its vaccine is 95% effective on the basis of Phase -3 trial .On Friday Pfizer has said its asking US regulators to allow emergency use of its COVID-19 vaccine.They have announced to submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Autorization which will potentially enable the use of the vaccine in high-risk populations in the U.S by the middle to end of December 2020, Statement released by Pfizer

“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr.Albert Borla, Pfizer , chairman and Ceo

Recommended For You